These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8527272)

  • 1. The effect of delay, multiple actuations and spacer static charge on the in vitro delivery of budesonide from the Nebuhaler.
    Barry PW; O'Callaghan C
    Br J Clin Pharmacol; 1995 Jul; 40(1):76-8. PubMed ID: 8527272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhalational drug delivery from seven different spacer devices.
    Barry PW; O'Callaghan C
    Thorax; 1996 Aug; 51(8):835-40. PubMed ID: 8795674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of beclomethasone dipropionate from a spacer device: what dose is available for inhalation?
    O'Callaghan C; Cant M; Robertson C
    Thorax; 1994 Oct; 49(10):961-4. PubMed ID: 7974311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple actuations of salbutamol MDI into a spacer device reduce the amount of drug recovered in the respirable range.
    Barry PW; O'Callaghan C
    Eur Respir J; 1994 Sep; 7(9):1707-9. PubMed ID: 7995401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of electrostatic charge, flow, delay and multiple actuations on the in vitro delivery of salbutamol from different small volume spacers for infants.
    Wildhaber JH; Devadason SG; Eber E; Hayden MJ; Everard ML; Summers QA; LeSouëf PN
    Thorax; 1996 Oct; 51(10):985-8. PubMed ID: 8977597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a spacer on total systemic and lung bioavailability in healthy volunteers and in vitro performance of the Symbicort
    Gillen M; Forte P; Svensson JO; Lamarca R; Burke J; Rask K; Larsdotter Nilsson U; Eckerwall G
    Pulm Pharmacol Ther; 2018 Oct; 52():7-17. PubMed ID: 30077809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in sodium cromoglycate delivery from a spacer device by use of an antistatic lining, immediate inhalation, and avoiding multiple actuations of drug.
    O'Callaghan C; Lynch J; Cant M; Robertson C
    Thorax; 1993 Jun; 48(6):603-6. PubMed ID: 8346488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The output of budesonide from spacer devices assessed under simulated breathing conditions.
    Barry PW; O'Callaghan C
    J Allergy Clin Immunol; 1999 Dec; 104(6):1205-10. PubMed ID: 10589002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A non-electrostatic spacer for aerosol delivery.
    Bisgaard H; Anhøj J; Klug B; Berg E
    Arch Dis Child; 1995 Sep; 73(3):226-30. PubMed ID: 7492160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of spacer device on drug delivery to young children with asthma.
    Agertoft L; Pedersen S
    Arch Dis Child; 1994 Sep; 71(3):217-9; discussion 219-20. PubMed ID: 7979494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower oropharyngeal deposition of inhaled ciclesonide via hydrofluoroalkane metered-dose inhaler compared with budesonide via chlorofluorocarbon metered-dose inhaler in healthy subjects.
    Nave R; Zech K; Bethke TD
    Eur J Clin Pharmacol; 2005 May; 61(3):203-8. PubMed ID: 15824911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhalation of single vs multiple metered-dose bronchodilator actuations from reservoir devices. An in vitro study.
    Rau JL; Restrepo RD; Deshpande V
    Chest; 1996 Apr; 109(4):969-74. PubMed ID: 8635379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of the inhalation device on the effect of budesonide.
    Agertoft L; Pedersen S
    Arch Dis Child; 1993 Jul; 69(1):130-3. PubMed ID: 8024295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Interval Between Actuations of Albuterol Hydrofluoroalkane Pressurized Metered-Dose Inhalers on Their Aerosol Characteristics.
    Berlinski A; Pennington D
    Respir Care; 2017 Sep; 62(9):1123-1130. PubMed ID: 28611228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting total and "respirable" dose delivered by a salbutamol metered dose inhaler.
    Everard ML; Devadason SG; Summers QA; Le Souëf PN
    Thorax; 1995 Jul; 50(7):746-9. PubMed ID: 7570408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy and safety of budesonide Turbuhaler as compared to MDIs in children.
    Pedersen S
    J Aerosol Med; 1994; 7(Suppl 1):S67-71. PubMed ID: 10147083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equally efficacious asthma management with budesonide 800 micrograms administered by Turbuhaler or with beclomethasone dipropionate > or = 1500 micrograms given through a pressurized metered-dose inhaler with spacer. The French Budesonide Trial Group.
    Piquet J; Zuck P; Dennewald G; Dugue P; Grivaux M; Brun P; Severac JC; Ostinelli J; Cheeseman KH
    Adv Ther; 1996; 13(1):38-50. PubMed ID: 10172710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic effects of high dose inhaled steroids: comparison of beclomethasone dipropionate and budesonide in healthy subjects.
    Brown PH; Matusiewicz SP; Shearing C; Tibi L; Greening AP; Crompton GK
    Thorax; 1993 Oct; 48(10):967-73. PubMed ID: 8256242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of multiple actuations, delayed inhalation and antistatic treatment on the lung bioavailability of salbutamol via a spacer device.
    Clark DJ; Lipworth BJ
    Thorax; 1996 Oct; 51(10):981-4. PubMed ID: 8977596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative bioavailability of salbutamol to the lung following inhalation using metered dose inhalation methods and spacer devices.
    Hindle M; Chrystyn H
    Thorax; 1994 Jun; 49(6):549-53. PubMed ID: 8016791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.